HFS
IMVT icon

Hughes Financial Services’s Immunovant IMVT Stock Holding History

Hughes Financial Services’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25 Buy
+1
New +$26 ﹤0.01% 1577

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Hughes Financial Services's IMVT Position: Q1 2026 in Review

Hughes Financial Services opened a new position in Immunovant (IMVT) in Q1 2026: 1 share worth $25. The stake represents ﹤0.01% of the portfolio and ranks #1577 among its holdings.

215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Hughes Financial Services held 1 share of Immunovant worth $25 as of Q1 2026.
  • Immunovant was a new Hughes Financial Services position in Q1 2026.
  • Immunovant made up ﹤0.01% of Hughes Financial Services's portfolio in Q1 2026, its #1577 holding.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Hughes Financial Services's 13F filing for Q1 2026, filed 29 Apr 2026.